4892.T
Price:
$1063
Market Cap:
$8.83B
Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-12-01
Stock Exchange
JPX
Ticker
4892.T
According to Cyfuse Biomedical K.K.’s latest financial reports and current stock price. The company's current PE Ratio is -9.81. This represents a change of 71.44% compared to the average of -5.72 of the last 4 quarters.
The mean historical PE Ratio of Cyfuse Biomedical K.K. over the last ten years is -10.92. The current -9.81 PE Ratio has changed 8.89% with respect to the historical average. Over the past ten years (40 quarters), 4892.T's PE Ratio was at its highest in in the December 2024 quarter at -4.42. The PE Ratio was at its lowest in in the December 2023 quarter at -27.29.
Average
-10.92
Median
-7.32
Minimum
-39.33
Maximum
6.35
Discovering the peaks and valleys of Cyfuse Biomedical K.K. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.98%
Maximum Annual PE Ratio = 6.35
Minimum Annual Increase = -215.26%
Minimum Annual PE Ratio = -39.33
Year | PE Ratio | Change |
---|---|---|
2024 | -4.17 | -58.71% |
2023 | -10.10 | 37.98% |
2022 | -7.32 | -215.26% |
2021 | 6.35 | -116.15% |
The current PE Ratio of Cyfuse Biomedical K.K. (4892.T) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.20
5-year avg
-10.92
10-year avg
-10.92
Cyfuse Biomedical K.K.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyfuse Biomedical K.K. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cyfuse Biomedical K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cyfuse Biomedical K.K.'s PE Ratio?
How is the PE Ratio calculated for Cyfuse Biomedical K.K. (4892.T)?
What is the highest PE Ratio for Cyfuse Biomedical K.K. (4892.T)?
What is the 3-year average PE Ratio for Cyfuse Biomedical K.K. (4892.T)?
What is the 5-year average PE Ratio for Cyfuse Biomedical K.K. (4892.T)?
How does the current PE Ratio for Cyfuse Biomedical K.K. (4892.T) compare to its historical average?